| |
| | [No title] (Site not responding. Last check: 2007-10-09) |
 | | Massive postpartum hemorrhage (MPPH) that might be fatal, is seen with uterine rupture, placental abruption, uterine atony, placenta accreta, placenta praevia, retained placenta, coagulation defects and trauma to the genital tract. |
 | | In a study of 763 pregnant women, who died due to hemorrhage, 141(19%) had placental abruption, 125 (16%) uterine rupture, 115 (15%) uterine atony, 108(14%) coagulopathies, 50 (7%) placenta praevia, 44(6%) placenta accreta, 44(6%) uterine bleeding and 32(4%) retained placenta (2). |
 | | NovoSeven® was used and is indicated with massive postpartum hemorrhage: 1) in a fatal situation when no other treatment is available, 2) in a young bleeding parturient before the decision of hysterectomy and 3) for a temporary decrease of bleeding to achieve better surgical hemostasis. |
| www.kenes.com /controversies/cogi5/abstracts/Segal.doc (1168 words) |
|